Ligand Pharmaceuticals Inc (LGND)
109.86
-0.18
(-0.16%)
USD |
NASDAQ |
Nov 04, 13:04
Ligand Pharmaceuticals Shareholders Equity (Quarterly): 775.20M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 775.20M |
| March 31, 2024 | 806.52M |
| December 31, 2023 | 700.91M |
| September 30, 2023 | 667.90M |
| June 30, 2023 | 664.89M |
| March 31, 2023 | 646.32M |
| December 31, 2022 | 597.48M |
| September 30, 2022 | 816.30M |
| June 30, 2022 | 802.36M |
| March 31, 2022 | 793.19M |
| December 31, 2021 | 821.16M |
| September 30, 2021 | 812.07M |
| June 30, 2021 | 786.52M |
| March 31, 2021 | 745.84M |
| December 31, 2020 | 709.52M |
| September 30, 2020 | 697.82M |
| June 30, 2020 | 695.00M |
| March 31, 2020 | 661.90M |
| December 31, 2019 | 767.23M |
| September 30, 2019 | 850.58M |
| June 30, 2019 | 1.041B |
| March 31, 2019 | 1.080B |
| December 31, 2018 | 560.91M |
| September 30, 2018 | 699.52M |
| June 30, 2018 | 619.81M |
| Date | Value |
|---|---|
| March 31, 2018 | 497.18M |
| December 31, 2017 | 418.65M |
| September 30, 2017 | 424.76M |
| June 30, 2017 | 409.41M |
| March 31, 2017 | 398.78M |
| December 31, 2016 | 370.85M |
| September 30, 2016 | 370.39M |
| June 30, 2016 | 391.92M |
| March 31, 2016 | 392.08M |
| December 31, 2015 | 276.91M |
| September 30, 2015 | 292.18M |
| June 30, 2015 | 69.05M |
| March 31, 2015 | 35.15M |
| December 31, 2014 | 26.32M |
| September 30, 2014 | 44.37M |
| June 30, 2014 | 64.17M |
| March 31, 2014 | 65.00M |
| December 31, 2013 | 49.61M |
| September 30, 2013 | 44.82M |
| June 30, 2013 | 39.27M |
| March 31, 2013 | 30.60M |
| December 31, 2012 | 26.48M |
| September 30, 2012 | 21.24M |
| June 30, 2012 | 18.45M |
| March 31, 2012 | 19.24M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
597.48M
Minimum
Dec 2022
821.16M
Maximum
Dec 2021
735.17M
Average
745.84M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 29.33B |
| Agios Pharmaceuticals Inc | 660.51M |
| ADMA Biologics Inc | 188.27M |
| Pieris Pharmaceuticals Inc | 18.70M |
| AnaptysBio Inc | 9.879M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 866.40M |
| Total Liabilities (Quarterly) | 91.21M |
| Current Ratio | 16.82 |
| Net Debt Paydown Yield | 1.01% |